Clinical Trial Update: Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fludarabine phosphate with low-dose total-body irradiation and peripheral blood stem cell transplant, followed by donor lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Accelerated Phase of Disease
• Childhood Chronic Myelogenous Leukemia Bcr-abl1 Positive
• Chronic Myeloid Leukemia
• Disease
• Phase of Disease

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Accelerated Phase of Disease, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 2 | Status: COMPLETED